$AbbVie(ABBV)$ @Trade Feed Dec

ABBV

11-18 08:05

USAbbVie

Side	Price \| Filled	Realized P&L
Buy Open	233.82 0	-4.34% Holding

AbbVie

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
11-18
Trade Feed Decoder
The AbbVie (ABBV) buy trade reflects a conservative approach given the stock's profile as a dividend-heavy pharmaceutical company with stable cash flows. A +0.45% realized gain suggests short-term profit-taking or disciplined risk management, as the modest return aligns with lower volatility typical of healthcare blue chips. The timing (if accurate) might indicate responsiveness to sector-specific catalysts like drug approvals or earnings stability. While the position size isn’t disclosed, the trade highlights a focus on incremental gains in defensive sectors, balancing growth and income. Traders could note the alignment with macroeconomic conditions favoring healthcare during uncertain markets, though the narrow profit margin underscores the importance of precise entry/exit execution.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":501278999667536,"tweetId":"501278999667536","gmtCreate":1763424361027,"gmtModify":1765921384887,"author":{"id":3549681432330574,"idStr":"3549681432330574","authorId":3549681432330574,"authorIdStr":"3549681432330574","name":"JordenTan","avatar":"https://static.tigerbbs.com/7e0fa95295d977d5a97deb7631a67dfc","vip":2,"userType":2,"introduction":"Program Lead at Startup Accelerator and Venture Capitalist.","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.18","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":481,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":321,"starInvestorOrderShareNum":30,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":91.01,"showRor":true,"investmentPhilosophy":"Invest and walk away for long term holdings. Use options to generate income","winRationPercentage":78.350515,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/ABBV\">$AbbVie(ABBV)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/ABBV\">$AbbVie(ABBV)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$AbbVie(ABBV)$ @Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":41,"commentSize":1,"repostSize":22,"favoriteSize":0,"link":"https://ttm.financial/post/501278999667536","repostId":0,"isVote":1,"tweetType":1,"viewCount":708,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ABBV"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3549681432330574","orderId":"41225436822372352","kind":"TRADE","symbol":"ABBV","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/ABBV\">$AbbVie(ABBV)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/ABBV","symbolName":"AbbVie","market":"US","action":"BUY","currency":"USD","symbolLogo":"https://static.tigerbbs.com/cadd7dc41b19a2bdeeaa3c3c02e1d84f","showFilledQuantity":true,"nameCN":"AbbVie","orderType":"LMT","filledQuantityFinal":0.03417,"avgFillPrice":233.82,"createTime":1763424322,"filledQuantity":"3417","filledQuantityScale":"5","openFlag":true,"side":"DEBIT","contractMajorDescription":"AbbVie","contractExtraDescription":"ABBV","legs":[],"completedFlag":false,"orderPnl":{"openRealizedPnlPercent":0,"openUnrealizedPnlPercent":-0.0434},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":501296446009752,"commentId":"501296446009752","gmtCreate":1763428536901,"gmtModify":1763429919580,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":501278999667536,"objectIdStr":"501278999667536","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"The AbbVie (ABBV) buy trade reflects a conservative approach given the stock's profile as a dividend-heavy pharmaceutical company with stable cash flows. A +0.45% realized gain suggests short-term profit-taking or disciplined risk management, as the modest return aligns with lower volatility typical of healthcare blue chips. The timing (if accurate) might indicate responsiveness to sector-specific catalysts like drug approvals or earnings stability. While the position size isn’t disclosed, the trade highlights a focus on incremental gains in defensive sectors, balancing growth and income. Traders could note the alignment with macroeconomic conditions favoring healthcare during uncertain markets, though the narrow profit margin underscores the importance of precise entry/exit execution.","text":"The AbbVie (ABBV) buy trade reflects a conservative approach given the stock's profile as a dividend-heavy pharmaceutical company with stable cash flows. A +0.45% realized gain suggests short-term profit-taking or disciplined risk management, as the modest return aligns with lower volatility typical of healthcare blue chips. The timing (if accurate) might indicate responsiveness to sector-specific catalysts like drug approvals or earnings stability. While the position size isn’t disclosed, the trade highlights a focus on incremental gains in defensive sectors, balancing growth and income. Traders could note the alignment with macroeconomic conditions favoring healthcare during uncertain markets, though the narrow profit margin underscores the importance of precise entry/exit execution.","html":"The AbbVie (ABBV) buy trade reflects a conservative approach given the stock's profile as a dividend-heavy pharmaceutical company with stable cash flows. A +0.45% realized gain suggests short-term profit-taking or disciplined risk management, as the modest return aligns with lower volatility typical of healthcare blue chips. The timing (if accurate) might indicate responsiveness to sector-specific catalysts like drug approvals or earnings stability. While the position size isn’t disclosed, the trade highlights a focus on incremental gains in defensive sectors, balancing growth and income. Traders could note the alignment with macroeconomic conditions favoring healthcare during uncertain markets, though the narrow profit margin underscores the importance of precise entry/exit execution.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/501278999667536"}